Helene Vanacker

4PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.

Allison Voisin, Catherine Terret, Camille Schiffler

|Jan 05, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.

Hélène Vanacker, Isabelle Treilleux, Camille Schiffler

|Mar 29, 2023
Immunotherapy for Soft Tissue Sarcomas: Anti-PD1/PDL1 and Beyond.

Mina Fazel, Armelle Dufresne, Hélène Vanacker

Pageof 1